Founded in 2013, CHO Pharma is committed to leveraging innovative sugar platform technology to create new drugs and advance the diagnosis and treatment of carbohydrate-related diseases. With a vision to become a prominent biopharmaceutical company in the field of sugar molecular technology, CHO Pharma focuses on developing highly effective drugs with minimal side effects. Additionally, they aim to enhance early detection methods, enabling patients to receive superior medical treatment through their cutting-edge research, development, and expertise.